drugset / Trial / NCT01860040
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To determine the rate of pathologic complete responses (pCR) at the time of definitive surgical resection of non-small cell lung cancer (NSCLC)
Timeline
- Start
- 2013-04
- Primary completion
- 2014-09
- Completion
- 2016-04
Outcome
Outcome not reported
Stopped (Enrollment): “Poor accrual, no data to analyze”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Pemetrexed | Small molecule | — | — |